Prediction of Spontaneous Puberty in Turner Syndrome Based on Mid-Childhood Gonadotropin Concentrations, Karyotype, and Ovary Visualization: A Longitudinal Study

Horm Res Paediatr. 2018;89(2):90-97. doi: 10.1159/000485321. Epub 2017 Dec 22.

Abstract

Aims: To investigate whether karyotype, mid-childhood (6-10 years) follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels, and ultrasound ovary visualization results can be used as indicators of spontaneous puberty in Turner syndrome (TS).

Methods: The analysis was based on clinical and biochemical data from 110 TS girls aged >13 years at the end of the study (1,140 visits between 1996 and 2015). The study population was divided according to karyotype: 45,X and non-45,X.

Results: The mean age ± standard deviation at diagnosis was 10.7 ± 4.0 years, and the follow-up duration was 5.9 ± 3.3 years. Spontaneous puberty was confirmed in 48% and menarche in 20% of the subjects, less frequently in 45,X girls. The mean age at Tanner stage B2 was 13.7 ± 2.4 years and that at menarche 14.2 ± 1.7 years, regardless of the karyotype. The median FSH level at 6-10 years was 8.16 IU/L, which was significantly lower than <6 years and >10 years. The median LH level at 6-10 years was 0.35 IU/L, which was lower than >10 years. The chance of spontaneous menarche was decreased in girls with FSH ≥6.7 IU/L between 6 and 10 years.

Conclusions: Although spontaneous puberty and menarche occur more frequently in non-45,X girls, the karyotype cannot be used to predict them. However, the chance of spontaneous menarche can be predicted based on gonadotropin cut-off values. There was no correlation between ultrasound ovary visualization results and spontaneous puberty.

Keywords: Gonadotropin; Karyotype; Menarche; Puberty; Tuner syndrome.

MeSH terms

  • Adolescent
  • Child
  • Female
  • Follicle Stimulating Hormone / blood*
  • Humans
  • Karyotype*
  • Karyotyping
  • Longitudinal Studies
  • Luteinizing Hormone / blood*
  • Ovary / diagnostic imaging*
  • Puberty / physiology*
  • Turner Syndrome / blood*
  • Turner Syndrome / diagnostic imaging
  • Turner Syndrome / genetics
  • Ultrasonography

Substances

  • Luteinizing Hormone
  • Follicle Stimulating Hormone